Table of Contents
Chapter 1. Global Genotyping Market Executive Summary
1.1. Global Genotyping Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Technology
1.3.3. By Application
1.3.4. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Genotyping Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Genotyping Market Dynamics
3.1. Market Drivers
3.1.1. Increasing prevalence of genetic disorders
3.1.2. Rising demand for personalized medicine
3.2. Market Challenges
3.2.1. High Cost associated with genotyping equipment and procedures
3.2.2. Concerns regarding data privacy and ethical issues related to genetic testing
3.3. Market Opportunities
3.3.1. Growing adoption of next-generation sequencing (NGS) technologies
3.3.2. Increased government funding for genomics research
Chapter 4. Global Genotyping Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Genotyping Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Instruments
5.3 Reagents & Kits
5.4 Software and Services
Chapter 6. Global Genotyping Market Size & Forecasts by Technology 2022-2032
6.1. Segment Dashboard
6.2. PCR
6.3 Capillary Electrophoresis
6.4. Microarrays
6.5. Sequencing
6.6. Mass Spectrometry
6.7. Others
Chapter 7. Global Genotyping Market Size & Forecasts by Application 2022-2032
7.1. Segment Dashboard
7.2. Pharmacogenomics
7.3. Diagnostics and Personalized Medicine
7.4 Agricultural Biotechnology
7.5. Animal Genetics
7.6. Others
Chapter 8. Global Genotyping Market Size & Forecasts by End-Use 2022-2032
8.1. Segment Dashboard
8.2. Pharmaceutical and Biopharmaceutical Companies
8.3. Diagnostics and Research Laboratories
8.4. Academic Institutes
8.5. Others
Chapter 9. Global Genotyping Market Size & Forecasts by Region 2022-2032
9.1. North America Genotyping market
9.1.1. U.S. Genotyping market
9.1.1.1. By Product breakdown size & forecasts, 2022-2032
9.1.1.2. By Technology breakdown size & forecasts, 2022-2032
9.1.1.3. By Application breakdown size & forecasts, 2022-2032
9.1.1.4. By End-Use breakdown size & forecasts, 2022-2032
9.1.2. Canada Genotyping market
9.2. Europe Genotyping market
9.2.1. U.K. Genotyping market
9.2.2. Germany Genotyping market
9.2.3. France Genotyping market
9.2.4. Italy Genotyping market
9.2.5. Spain Genotyping market
9.2.6. Rest of Europe Genotyping market
9.3. Asia-Pacific Genotyping market
9.3.1. China Genotyping market
9.3.2. India Genotyping market
9.3.3. Japan Genotyping market
9.3.4. Australia Genotyping market
9.3.5. South Korea Genotyping market
9.3.6. Rest of Asia-Pacific Genotyping market
9.4. Latin America Genotyping market
9.4.1. Brazil Genotyping market
9.4.2. Mexico Genotyping market
9.4.3 Rest of Latin America Genotyping market
9.5. Middle East and Africa Genotyping market
9.4.2. Saudi Arabia Genotyping market
9.4.3. South Africa Genotyping market
9.4.4. Rest of Middle East and Africa Genotyping market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1.
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Illumina Inc.
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Thermo Fisher Scientific Inc.
10.3.3. Qiagen N.V
10.3.4. F. Hoffmann-La Roche Ltd.
10.3.5. Fluidigm Corporation
10.3.6. Danaher Corporation
10.3.7. Agilent Technologies
10.3.8. Eurofins Scientific Inc.
10.3.9. GE Healthcare Inc.
10.3.10. Bio-Rad Laboratories Inc.
10.3.11. PerkinElmer, Inc.
10.3.12. Roche Diagnostics
10.3.13. Eurofins Scientific
10.3.14. LGC Limited
10.3.15. Oxford Nanopore Technologies
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes